Medtronic plc, a global leader in health care technology, announced today that the U.S. Department of Veterans Affairs (VA) has awarded a three-year Indefinite Delivery Indefinite Quantity (IDIQ) contract for GI Genius™ AI-powered endoscopy units, resulting in almost 100 additional units being installed across VA medical centers nationwide. This expansion underscores the ability of Medtronic’s proven technology to deliver state-of-the-art care to veterans, aiming to provide gold-standard diagnostic accuracy in colorectal screenings for thousands who served.

“We’re truly honored to expand our work with the VA to bring AI innovation directly to more patients, especially to Veterans who have proudly served our Nation,” said Raj Thomas, vice president and president of the Endoscopy business, which is part of the Medical Surgical Portfolio at Medtronic. “Colorectal cancer remains one of the most commonly diagnosed cancers among Veterans, and this partnership is more than technology — it’s about setting a new benchmark in care with AI-driven precision to support earlier, more accurate diagnoses. This commitment advances our fight against colorectal cancer and reinforces Medtronic’s mission to deliver life-changing care to patients everywhere."

Through a partnership with a Service-Disabled Veteran-Owned Small Business (SDVOSB), this contract is a result of several years of groundwork and implementation with the VA which includes over 360 GI Genius™ units installed across over 140 VA facilities in the United States and Puerto Rico, marking a significant step in expanding access to AI-assisted colonoscopies throughout the VA network. The VA performs approximately 250,000 colonoscopies each year¹, diagnosing around 4,000 new cases of colorectal cancer annually².

Equipped with AI-driven technology, which can reduce missed polyps by up to 50%³, GI Genius™ offers VA clinicians unparalleled support in early detection and potentially life-saving insights. The expansion of Medtronic’s GI Genius™ technology furthers the adoption of cutting-edge tools to fight against this cancer.

The U.S. Department of Veterans Affairs does not support nor endorse individual vendors.

About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ passionate people across 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary.  For more information on Medtronic, visit www.Medtronic.com and follow on LinkedIn.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Contacts:
Sabrina Zimring
Public Relations
+1-508-261-8000

Ryan Weispfenning
Investor Relations
+1-763-505-4626

References:

¹ The Veterans Health Administration (VHA) has indicated that their medical centers perform approximately 250,000 colonoscopies per year.
²VA diagnoses 4,000 cases of colon cancer each year. VA News blog, Mar. 21, 2019.
³ Wallace MB, Sharma P, Bhandari P, et al. Impact of Artificial Intelligence on Miss Rate of Colorectal Neoplasia. Gastroenterology. 2022;163(1):295. doi:10.1053/j.gastro.2022.03.007